Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 1083618 | 1 page | https://doi.org/10.1155/2017/1083618

Corrigendum to “Basic Fibroblast Growth Factor Inhibits Apoptosis and Promotes Proliferation of Adipose-Derived Mesenchymal Stromal Cells Isolated from Patients with Type 2 Diabetes by Reducing Cellular Oxidative Stress”

Received05 Mar 2017
Accepted06 Apr 2017
Published16 May 2017

In the article titled “Basic Fibroblast Growth Factor Inhibits Apoptosis and Promotes Proliferation of Adipose-Derived Mesenchymal Stromal Cells Isolated from Patients with Type 2 Diabetes by Reducing Cellular Oxidative Stress” [1], an acknowledgment should be added as follows:

“Publication was supported by the Wrocław Centre of Biotechnology programme, the Leading National Research Centre (KNOW) for years 2014–2018.”

References

  1. D. Nawrocka, K. Kornicka, J. Szydlarska, and K. Marycz, “Basic fibroblast growth factor inhibits apoptosis and promotes proliferation of adipose-derived mesenchymal stromal cells isolated from patients with type 2 diabetes by reducing cellular oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 3027109, 22 pages, 2017. View at: Publisher Site | Google Scholar

Copyright © 2017 Daria Nawrocka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

526 Views | 196 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.